Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Infarction | 31 | 2024 | 11824 | 3.240 |
Why?
|
Israel | 26 | 2022 | 807 | 2.590 |
Why?
|
Serum Albumin | 4 | 2021 | 680 | 2.180 |
Why?
|
Potassium | 5 | 2020 | 1329 | 1.510 |
Why?
|
Lipoprotein(a) | 3 | 2024 | 460 | 1.440 |
Why?
|
Patient Admission | 4 | 2019 | 1390 | 1.240 |
Why?
|
Registries | 8 | 2024 | 8216 | 1.180 |
Why?
|
Coronary Artery Disease | 9 | 2024 | 6565 | 1.170 |
Why?
|
Myocarditis | 3 | 2022 | 770 | 1.130 |
Why?
|
Aortic Valve Stenosis | 5 | 2024 | 1976 | 1.110 |
Why?
|
Chemical Warfare | 3 | 2015 | 18 | 1.040 |
Why?
|
Atrial Fibrillation | 6 | 2021 | 5064 | 1.020 |
Why?
|
Hospital Mortality | 8 | 2020 | 5367 | 0.960 |
Why?
|
Survivors | 4 | 2018 | 2336 | 0.890 |
Why?
|
Out-of-Hospital Cardiac Arrest | 2 | 2015 | 349 | 0.740 |
Why?
|
Jews | 4 | 2020 | 387 | 0.720 |
Why?
|
Arabs | 4 | 2020 | 185 | 0.710 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2020 | 113 | 0.700 |
Why?
|
Extracellular Space | 1 | 2021 | 596 | 0.690 |
Why?
|
Bundle-Branch Block | 1 | 2021 | 271 | 0.690 |
Why?
|
Time Factors | 24 | 2021 | 40195 | 0.680 |
Why?
|
Embolic Protection Devices | 1 | 2019 | 42 | 0.680 |
Why?
|
Vitamin K | 1 | 2021 | 302 | 0.670 |
Why?
|
Hypoalbuminemia | 1 | 2019 | 86 | 0.660 |
Why?
|
Drug Substitution | 1 | 2021 | 285 | 0.650 |
Why?
|
Dichlorvos | 1 | 2018 | 1 | 0.640 |
Why?
|
Aspirin | 2 | 2021 | 3332 | 0.630 |
Why?
|
Chemical Warfare Agents | 2 | 2015 | 21 | 0.600 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2023 | 552 | 0.600 |
Why?
|
Risk Factors | 32 | 2024 | 73094 | 0.600 |
Why?
|
Retrospective Studies | 37 | 2024 | 78758 | 0.590 |
Why?
|
Decision Support Techniques | 2 | 2018 | 1984 | 0.590 |
Why?
|
Acute Coronary Syndrome | 2 | 2021 | 2348 | 0.590 |
Why?
|
Aged | 46 | 2024 | 165629 | 0.570 |
Why?
|
Electrocardiography | 5 | 2021 | 6458 | 0.560 |
Why?
|
Holocaust | 1 | 2016 | 34 | 0.550 |
Why?
|
Patient Discharge | 4 | 2021 | 3356 | 0.540 |
Why?
|
Cardiovascular Diseases | 6 | 2024 | 15433 | 0.530 |
Why?
|
Risk Assessment | 13 | 2024 | 23554 | 0.530 |
Why?
|
Male | 62 | 2024 | 354311 | 0.520 |
Why?
|
Hospitalization | 10 | 2022 | 10422 | 0.520 |
Why?
|
Plaque, Atherosclerotic | 2 | 2024 | 1529 | 0.520 |
Why?
|
Hyponatremia | 1 | 2018 | 286 | 0.520 |
Why?
|
Aftercare | 2 | 2021 | 885 | 0.510 |
Why?
|
Heart Massage | 1 | 2014 | 30 | 0.500 |
Why?
|
Aortic Valve | 3 | 2024 | 1934 | 0.500 |
Why?
|
Patient Acceptance of Health Care | 5 | 2022 | 3069 | 0.490 |
Why?
|
Allied Health Personnel | 2 | 2015 | 161 | 0.490 |
Why?
|
Infarction | 1 | 2016 | 250 | 0.480 |
Why?
|
Female | 61 | 2024 | 385090 | 0.480 |
Why?
|
Aged, 80 and over | 22 | 2024 | 58361 | 0.480 |
Why?
|
Predictive Value of Tests | 14 | 2024 | 15164 | 0.480 |
Why?
|
Mustard Gas | 1 | 2014 | 15 | 0.480 |
Why?
|
Heart Conduction System | 2 | 2024 | 1044 | 0.450 |
Why?
|
Health Resources | 1 | 2020 | 920 | 0.450 |
Why?
|
Drug-Eluting Stents | 1 | 2020 | 758 | 0.450 |
Why?
|
Long QT Syndrome | 1 | 2018 | 454 | 0.450 |
Why?
|
Humans | 82 | 2024 | 752741 | 0.440 |
Why?
|
Sodium | 1 | 2018 | 1625 | 0.430 |
Why?
|
Heart | 3 | 2023 | 4458 | 0.420 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 784 | 0.420 |
Why?
|
Eosinophils | 1 | 2017 | 966 | 0.410 |
Why?
|
Ventricular Fibrillation | 1 | 2014 | 541 | 0.410 |
Why?
|
Heart Rate | 4 | 2018 | 4108 | 0.400 |
Why?
|
Defibrillators, Implantable | 3 | 2011 | 1464 | 0.400 |
Why?
|
Action Potentials | 2 | 2024 | 1807 | 0.400 |
Why?
|
Middle Aged | 39 | 2024 | 216054 | 0.400 |
Why?
|
Electric Countershock | 1 | 2014 | 534 | 0.390 |
Why?
|
Gymnema sylvestre | 1 | 2010 | 2 | 0.390 |
Why?
|
Acute Kidney Injury | 2 | 2020 | 1894 | 0.390 |
Why?
|
Self Efficacy | 1 | 2015 | 623 | 0.380 |
Why?
|
Mortality | 4 | 2018 | 2899 | 0.380 |
Why?
|
Leisure Activities | 1 | 2013 | 311 | 0.380 |
Why?
|
Herpes Simplex | 1 | 2014 | 473 | 0.380 |
Why?
|
Citalopram | 1 | 2013 | 403 | 0.370 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2015 | 1005 | 0.360 |
Why?
|
Chest Tubes | 1 | 2011 | 149 | 0.360 |
Why?
|
Survival Rate | 6 | 2021 | 12802 | 0.350 |
Why?
|
Myocardium | 3 | 2023 | 4719 | 0.350 |
Why?
|
Agranulocytosis | 1 | 2009 | 101 | 0.340 |
Why?
|
Respiratory Mechanics | 2 | 2010 | 696 | 0.340 |
Why?
|
Lymphocytes | 1 | 2017 | 2617 | 0.330 |
Why?
|
Follow-Up Studies | 12 | 2022 | 39223 | 0.330 |
Why?
|
Equipment Failure | 1 | 2011 | 579 | 0.330 |
Why?
|
Coronary Vessels | 1 | 2020 | 3147 | 0.320 |
Why?
|
Phytotherapy | 1 | 2010 | 296 | 0.320 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2019 | 2088 | 0.320 |
Why?
|
Emergency Service, Hospital | 4 | 2022 | 7766 | 0.320 |
Why?
|
Atrial Flutter | 1 | 2010 | 262 | 0.310 |
Why?
|
Anticoagulants | 2 | 2021 | 4738 | 0.310 |
Why?
|
Prognosis | 12 | 2020 | 29264 | 0.310 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2761 | 0.300 |
Why?
|
Comorbidity | 7 | 2021 | 10450 | 0.300 |
Why?
|
Hepatitis, Autoimmune | 1 | 2009 | 146 | 0.300 |
Why?
|
Thromboembolism | 1 | 2014 | 996 | 0.290 |
Why?
|
Pneumothorax | 1 | 2011 | 381 | 0.290 |
Why?
|
Military Personnel | 1 | 2015 | 1162 | 0.270 |
Why?
|
Prevalence | 5 | 2021 | 15404 | 0.270 |
Why?
|
Decompression, Surgical | 1 | 2011 | 608 | 0.260 |
Why?
|
Incidence | 5 | 2024 | 21146 | 0.260 |
Why?
|
Stroke | 2 | 2021 | 10152 | 0.260 |
Why?
|
Coronary Angiography | 6 | 2023 | 4598 | 0.260 |
Why?
|
Health Status | 1 | 2018 | 4077 | 0.260 |
Why?
|
Syncope | 1 | 2008 | 435 | 0.250 |
Why?
|
Neutrophils | 1 | 2017 | 3729 | 0.240 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3218 | 0.240 |
Why?
|
Calcium | 1 | 2018 | 5774 | 0.240 |
Why?
|
Blood Glucose | 1 | 2019 | 6318 | 0.240 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2007 | 365 | 0.230 |
Why?
|
Ventricular Septum | 1 | 2024 | 74 | 0.230 |
Why?
|
Exercise Test | 2 | 2011 | 2090 | 0.220 |
Why?
|
Clinical Competence | 3 | 2015 | 4729 | 0.220 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1950 | 0.220 |
Why?
|
Myocardial Ischemia | 1 | 2013 | 2152 | 0.210 |
Why?
|
Depression | 2 | 2016 | 7876 | 0.210 |
Why?
|
Treatment Outcome | 9 | 2024 | 64017 | 0.210 |
Why?
|
Atropine | 3 | 2018 | 245 | 0.210 |
Why?
|
Tachycardia, Ventricular | 1 | 2011 | 1286 | 0.210 |
Why?
|
Primary Health Care | 1 | 2019 | 4624 | 0.210 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5799 | 0.210 |
Why?
|
Vaccination | 3 | 2022 | 3354 | 0.200 |
Why?
|
Mass Casualty Incidents | 2 | 2014 | 183 | 0.200 |
Why?
|
Hospital Costs | 1 | 2008 | 983 | 0.200 |
Why?
|
Obidoxime Chloride | 2 | 2018 | 2 | 0.190 |
Why?
|
Stress, Psychological | 3 | 2013 | 4316 | 0.190 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2023 | 136 | 0.180 |
Why?
|
Postoperative Complications | 2 | 2019 | 15459 | 0.180 |
Why?
|
Platelet Function Tests | 1 | 2021 | 270 | 0.170 |
Why?
|
Cause of Death | 3 | 2019 | 3628 | 0.170 |
Why?
|
Fingers | 2 | 2014 | 513 | 0.170 |
Why?
|
Pulsatile Flow | 2 | 2010 | 331 | 0.160 |
Why?
|
Coronary Disease | 1 | 2013 | 6083 | 0.160 |
Why?
|
Age Factors | 4 | 2021 | 18460 | 0.160 |
Why?
|
Costs and Cost Analysis | 2 | 2019 | 1687 | 0.160 |
Why?
|
Sex Factors | 4 | 2021 | 10469 | 0.160 |
Why?
|
Databases, Factual | 3 | 2021 | 7805 | 0.150 |
Why?
|
Physicians | 2 | 2015 | 4625 | 0.150 |
Why?
|
Atherosclerosis | 2 | 2024 | 3480 | 0.150 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2021 | 3123 | 0.150 |
Why?
|
Acute Disease | 2 | 2020 | 7221 | 0.150 |
Why?
|
Antidotes | 1 | 2018 | 140 | 0.150 |
Why?
|
Gadolinium | 1 | 2022 | 959 | 0.150 |
Why?
|
Poisoning | 2 | 2015 | 253 | 0.140 |
Why?
|
Health Care Costs | 2 | 2020 | 3217 | 0.140 |
Why?
|
Adult | 16 | 2024 | 216658 | 0.140 |
Why?
|
Platelet Aggregation | 1 | 2019 | 798 | 0.140 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15657 | 0.140 |
Why?
|
Military Medicine | 2 | 2015 | 179 | 0.130 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2022 | 977 | 0.130 |
Why?
|
Drug Utilization | 1 | 2021 | 1180 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2021 | 11909 | 0.130 |
Why?
|
Lymphocyte Count | 1 | 2017 | 788 | 0.130 |
Why?
|
Sarin | 1 | 2014 | 4 | 0.120 |
Why?
|
Fibrosis | 1 | 2021 | 2028 | 0.120 |
Why?
|
Nonlinear Dynamics | 1 | 2017 | 500 | 0.120 |
Why?
|
Chemical Terrorism | 1 | 2014 | 12 | 0.120 |
Why?
|
Hyperbilirubinemia | 1 | 2014 | 77 | 0.120 |
Why?
|
Iraq | 1 | 2014 | 92 | 0.120 |
Why?
|
Internal Medicine | 2 | 2011 | 1021 | 0.120 |
Why?
|
Administration, Oral | 1 | 2021 | 3941 | 0.110 |
Why?
|
Lung Transplantation | 1 | 2022 | 1139 | 0.110 |
Why?
|
Pulmonary Artery | 1 | 2022 | 1944 | 0.110 |
Why?
|
Odds Ratio | 3 | 2017 | 9863 | 0.110 |
Why?
|
Education, Nursing, Baccalaureate | 1 | 2012 | 23 | 0.110 |
Why?
|
Emergency Nursing | 1 | 2012 | 45 | 0.110 |
Why?
|
Prospective Studies | 6 | 2020 | 53863 | 0.100 |
Why?
|
Students, Nursing | 1 | 2012 | 46 | 0.100 |
Why?
|
Echocardiography | 3 | 2022 | 5117 | 0.100 |
Why?
|
International Normalized Ratio | 1 | 2014 | 375 | 0.100 |
Why?
|
Health Resorts | 1 | 2011 | 3 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1380 | 0.100 |
Why?
|
Contrast Media | 2 | 2022 | 5338 | 0.100 |
Why?
|
Length of Stay | 2 | 2020 | 6355 | 0.100 |
Why?
|
Young Adult | 7 | 2022 | 57267 | 0.100 |
Why?
|
Iran | 1 | 2014 | 722 | 0.100 |
Why?
|
Hypertension, Pulmonary | 1 | 2022 | 1554 | 0.100 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3500 | 0.090 |
Why?
|
Brain Edema | 1 | 2015 | 614 | 0.090 |
Why?
|
Students, Medical | 2 | 2013 | 1887 | 0.090 |
Why?
|
Blood Platelets | 1 | 2021 | 2526 | 0.090 |
Why?
|
Hospital Departments | 1 | 2010 | 137 | 0.090 |
Why?
|
Self-Assessment | 1 | 2012 | 389 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2022 | 20026 | 0.090 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2013 | 270 | 0.090 |
Why?
|
Medical Staff, Hospital | 2 | 2013 | 606 | 0.090 |
Why?
|
Heart Failure, Systolic | 1 | 2011 | 131 | 0.090 |
Why?
|
Quality of Life | 2 | 2011 | 13044 | 0.090 |
Why?
|
Coronary Artery Bypass | 1 | 2019 | 2275 | 0.090 |
Why?
|
Lipids | 2 | 2018 | 3326 | 0.090 |
Why?
|
Regional Blood Flow | 2 | 2010 | 1526 | 0.090 |
Why?
|
Photoplethysmography | 1 | 2010 | 58 | 0.090 |
Why?
|
Work Schedule Tolerance | 1 | 2013 | 544 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 2 | 2018 | 8285 | 0.090 |
Why?
|
Immunocompromised Host | 1 | 2014 | 847 | 0.080 |
Why?
|
Waist Circumference | 1 | 2013 | 924 | 0.080 |
Why?
|
Feedback | 1 | 2012 | 792 | 0.080 |
Why?
|
Respiratory Tract Diseases | 1 | 2014 | 727 | 0.080 |
Why?
|
Eye Diseases | 1 | 2014 | 673 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2018 | 1636 | 0.080 |
Why?
|
Drug Monitoring | 1 | 2014 | 945 | 0.080 |
Why?
|
Self Concept | 1 | 2013 | 1033 | 0.070 |
Why?
|
Sleep Deprivation | 1 | 2013 | 815 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5965 | 0.070 |
Why?
|
Positron-Emission Tomography | 1 | 2023 | 6364 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2018 | 2083 | 0.070 |
Why?
|
Complementary Therapies | 1 | 2010 | 485 | 0.070 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2009 | 647 | 0.070 |
Why?
|
Intubation, Intratracheal | 1 | 2014 | 1370 | 0.070 |
Why?
|
Health Expenditures | 1 | 2019 | 2371 | 0.070 |
Why?
|
Survival Analysis | 2 | 2016 | 10252 | 0.070 |
Why?
|
Motor Activity | 2 | 2013 | 2715 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12250 | 0.070 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2010 | 717 | 0.060 |
Why?
|
Skin Diseases | 1 | 2014 | 1073 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2011 | 13042 | 0.060 |
Why?
|
Warfarin | 1 | 2014 | 1515 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2024 | 20346 | 0.060 |
Why?
|
Logistic Models | 2 | 2017 | 13441 | 0.060 |
Why?
|
Steroids | 1 | 2009 | 940 | 0.060 |
Why?
|
Diagnostic Errors | 1 | 2010 | 1270 | 0.060 |
Why?
|
Cohort Studies | 5 | 2018 | 40939 | 0.050 |
Why?
|
Blood Pressure | 1 | 2018 | 8635 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2020 | 21904 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2022 | 35798 | 0.050 |
Why?
|
Smoking | 1 | 2018 | 9030 | 0.050 |
Why?
|
Hemorrhage | 1 | 2014 | 3530 | 0.050 |
Why?
|
Pain Measurement | 1 | 2011 | 3469 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18174 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2011 | 2295 | 0.050 |
Why?
|
Body Mass Index | 1 | 2018 | 12821 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 3966 | 0.050 |
Why?
|
Affect | 1 | 2007 | 1478 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2023 | 2030 | 0.040 |
Why?
|
Africa, Northern | 1 | 2018 | 85 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 7970 | 0.040 |
Why?
|
Middle East | 1 | 2018 | 224 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2014 | 4872 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2011 | 4344 | 0.030 |
Why?
|
Infant | 3 | 2014 | 35447 | 0.030 |
Why?
|
Paraoxon | 1 | 2015 | 2 | 0.030 |
Why?
|
Cholinesterase Reactivators | 1 | 2015 | 6 | 0.030 |
Why?
|
Models, Statistical | 1 | 2010 | 5107 | 0.030 |
Why?
|
Creatinine | 1 | 2020 | 1893 | 0.030 |
Why?
|
Scopolamine | 1 | 2015 | 98 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14761 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2007 | 3573 | 0.030 |
Why?
|
Protective Clothing | 1 | 2014 | 102 | 0.030 |
Why?
|
Syria | 1 | 2014 | 78 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2024 | 2264 | 0.030 |
Why?
|
Decontamination | 1 | 2014 | 70 | 0.030 |
Why?
|
Laryngeal Masks | 1 | 2014 | 99 | 0.030 |
Why?
|
Choline | 1 | 2015 | 503 | 0.030 |
Why?
|
Midazolam | 1 | 2015 | 271 | 0.030 |
Why?
|
Internship and Residency | 1 | 2013 | 5858 | 0.030 |
Why?
|
Maze Learning | 1 | 2015 | 485 | 0.030 |
Why?
|
Cholinergic Antagonists | 1 | 2014 | 165 | 0.030 |
Why?
|
Creatine | 1 | 2015 | 423 | 0.030 |
Why?
|
Aspartic Acid | 1 | 2015 | 577 | 0.030 |
Why?
|
Child, Preschool | 2 | 2012 | 41390 | 0.030 |
Why?
|
Adolescent | 3 | 2022 | 86713 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2014 | 1420 | 0.030 |
Why?
|
Atmospheric Pressure | 1 | 2011 | 47 | 0.030 |
Why?
|
Oceans and Seas | 1 | 2011 | 49 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3359 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2016 | 980 | 0.020 |
Why?
|
Obesity | 1 | 2013 | 12868 | 0.020 |
Why?
|
Altitude | 1 | 2011 | 160 | 0.020 |
Why?
|
Child | 3 | 2014 | 78594 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2015 | 1181 | 0.020 |
Why?
|
Staff Development | 1 | 2011 | 225 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2013 | 777 | 0.020 |
Why?
|
Obstetric Labor, Premature | 1 | 2011 | 278 | 0.020 |
Why?
|
Fourier Analysis | 1 | 2010 | 441 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2014 | 2043 | 0.020 |
Why?
|
Animals | 2 | 2018 | 169600 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2015 | 952 | 0.020 |
Why?
|
Nursing Staff, Hospital | 1 | 2011 | 345 | 0.020 |
Why?
|
Brain | 1 | 2015 | 26598 | 0.020 |
Why?
|
Disaster Planning | 1 | 2014 | 563 | 0.020 |
Why?
|
Workload | 1 | 2013 | 857 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2013 | 25454 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2457 | 0.020 |
Why?
|
United States | 1 | 2015 | 70772 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2015 | 1872 | 0.020 |
Why?
|
Recovery of Function | 1 | 2016 | 2950 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6493 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 1101 | 0.020 |
Why?
|
Weight Loss | 1 | 2015 | 2679 | 0.010 |
Why?
|
Delivery, Obstetric | 1 | 2011 | 949 | 0.010 |
Why?
|
Weight Gain | 1 | 2013 | 2317 | 0.010 |
Why?
|
ROC Curve | 1 | 2010 | 3558 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2010 | 1521 | 0.010 |
Why?
|
Health Status Disparities | 1 | 2013 | 1812 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6542 | 0.010 |
Why?
|
Cognition | 1 | 2015 | 6844 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2009 | 3715 | 0.010 |
Why?
|
Software | 1 | 2010 | 4460 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2010 | 4385 | 0.010 |
Why?
|
Pregnancy | 1 | 2011 | 29630 | 0.010 |
Why?
|